Contact Us

DESTINATION NEWS

Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

May 30, 2024

Antitumor efficacy of sunvozertinib was observed in patients regardless of baseline EGFR exon20ins status in plasma ctDNA.

Newrizon Partnered With Al Yemni Group, Bringing Its Futuristic EV Truck In GCC Region

May 30, 2024

RIYADH,Saudi Arabia,May 24,2024-- Recently in Riyadh,Newrizon,a startup dedicated in electrifying and revolutionizing urban delivery vehicles,signed dealership agreement and intent purchase order with

Tyligand Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and Orally Bioavailable KRAS G12D Inhibitor

May 30, 2024

SHANGHAI,May 24,2024--Tyligand Bioscience,a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies,announced that the first patient had been dosed

Compassionate closure for those who are unable to fulfil hopes and expectations of fertility treatment

May 30, 2024

MANILA,Philippines,May 24,2024-- Compassionate closure is a vital aspect of the holistic care of millions of people each year who are left with lost hopes and dreams of parenthood after assisted conc

Nagad becomes successful unicorn startup within 3 years

May 30, 2024

DHAKA,Bangladesh,May 24,2024-- Within just three years of its inception,Nagad,a leading mobile financial service provider based in Bangladesh,has established itself as the most successful startup uni

United in Our Fight Against Cancer - New Frontier Group Acquires Hong Kong Integrated Oncology Centre

May 30, 2024

HONG KONG,May 24,2024-- New Frontier Group (hereinafter referred to as "New Frontier") announces today that it has completed the acquisition of Hong Kong Integrated Oncology Centre (hereinaf

1 ... 332 333 334 335 336 337 338 ... 348